Ondansetron
15/74/01
Phase 3 small_molecule completed
Quick answer
Ondansetron for IBS - Irritable Bowel Syndrome is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- IBS - Irritable Bowel Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed